prior to the European Meeting on HIV & Hepatitis 2020

Virtual Meeting    27 OCTOBER 2020

EUROPEAN HIV CLINICAL FORUM

 
EUROPEAN HIV CLINICAL FORUM 2020: OPTIMIZING TREATMENT

The European HIV Clinical Forum 2020 provides an independent scientific program involving the world’s leading experts and is specifically designed for the European HIV healthcare professionals with the focus on optimizing treatment for their patients. The meeting is scheduled prior to the 18th European meeting on HIV & Hepatitis in Paris, France, which will allow healthcare professionals to combine both meetings in one trip thus limiting travel time and the number of days away from the clinic. 

This program will feature challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program will end with a networking reception for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

 
 
BACKGROUND

 

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.

 

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.

MATERIALS

HAVE A LOOK AT THE PREVIOUS MEETING'S PRESENTATIONS AND CONTENT HERE:

EUROPEAN HIV CLINICAL FORUM 2019

 

Last year's edition of the European HIV Clinical Forum was organized on 5 November 2019, prior to the EACS - 17th European AIDS Conference. The forum attracted nearly 80 participants, from 23 European countries. The focus of last year's meeting was on important clinical developments and updates on ongoing and new trials in the field of optimizing treatment. The program featured several invited lectures, abstracts and clinical cases discussions. The day ended with a social get together over drinks, providing a unique opportunity to meet colleagues from different countries.


Feedback from the participants showed that the workshop was very well received. All off the respondents indicated that the lectures have increased their knowledge, 98% agreed that the program was beneficial for the clinical management of their patients, and 97% reported that they intend to incorporate the new information from the workshop into the care of their patients.

 
FINAL PROGRAM - TUESDAY,27 OCTOBER 2020

    (CET)     

1:00 PM 

 Welcome, Introductions, and Goals

 Anne-Genevieve Marcelin,  PharmD, PhD, Hôpital Pitié-Salpétrière, France

SESSION 1 | State-of-the-Art Lectures: Update on Clinical Trials and Their Significance for Patient Management

Chairs: Anne-Genevieve Marcelin,  PharmD, PhD, Hôpital Pitié-Salpétrière, France

    (CET)     

1:10 PM 

Clinical update: Oral therapies for drug naïve and suppressed patients   

Gary Rubin, MD - University of Toronto, Canada

    (CET)     

1:25 PM 

Clinical update: Injectable drug regimens

Charles Flexner, MD - Johns Hopkins University School of Medicine, United States

    (CET)     

1:40 PM 

Clinical update: Highly treatment experienced patients

Michael Kozal, MD - Yale University, United States

    (CET)     

1:55 PM 

Discussion

    (CET)     

2:15 PM 

 

 Coffee Break

SESSION 2 | Reduced Drug Regimens: Scientific Considerations

Chairs: Jonathan Schapiro, MD, National Hemophilia Center, Sheba Medical Center,  Israel

    (CET)     

2:30 PM 

Virology: Implications for Resistance                          

Diane Descamps, MD, PhD - Hopital Bichat-claude Bernard, France

    (CET)     

2:45 PM 

Virology/Immunology: Implications for Reservoirs / Cure 

Mathias Lichterfeld, MD, PhD - Brigham and Women’s Hospital, Harvard Medical School, United States

    (CET)     

3:00 PM 

Pharmacology: Implications for poor adherence and sanctuary sites                                          Charles Flexner, MD - Johns Hopkins University School of Medicine, United States

    (CET)     

3:15 PM 

Discussion

    (CET)     

3:35 PM 

 

Coffee Break

SESSION 3 | Clinical Implementation of Long-Acting Therapies

Chairs: Charles Flexner, MD - Johns Hopkins University School of Medicine, United States

    (CET)     

3:50 PM 

Virological and Pharmacological monitoring: How and how often?                                              Andrea Calcagno, MD, DTM&H - University of Torino, Italy

    (CET)     

4:05 PM 

Management of drug-drug interactions and poor adherence

Kimberly Scarsi, PharmD, MS - University of Nebraska Medical Center, United States

    (CET)     

4:20 PM 

Financial considerations in oral versus parenteral HIV therapy    

Andrew Hill, MD - Liverpool University, United Kingdom

    (CET)     

4:35 PM 

Discussion

    (CET)     

4:55 PM 

 

Coffee Break

SESSION 4 | Roundtable: Social / Logistical Barriers to Implementation of PrEP in Europe: What’s the Same, What’s Different?

Moderators: Anton Pozniak, MD, FRCP -  Chelsea and Westminster Hospital, United Kingdom

    (CET)     

5:10 PM 

Southern Europe                                                                   

Pep Coll, MD - AIDS Research Institute-IrsiCaixa, Spain

    (CET)     

5:20 PM 

Western Europe

Christoph Boesecke, MD -  Universitätsklinikum Bonn, Germany

    (CET)     

5:30 PM 

Eastern Europe                                                                                          

David Jilich, MD - Hospital Na Bulovce, Czech Republic

    (CET)     

5:40 PM 

Roundtable Discussion

    (CET)     

6:00 PM 

Summary and Closure of Program 

Anton Pozniak, MD, FRCP -  Chelsea and Westminster Hospital, United Kingdom

 
PROGRAM DIRECTORS

Jonathan M. Schapiro, MD
National Hemophilia Center Sheba Medical Center
Israel

Charles Boucher, MD, PhD
Erasmus Medical Center
the Netherlands

LOCAL CHAIR

Anne-Geneviève

Marcelin, MD

Hôpital Pitié-Salpétrière

Paris, France

CME ACCREDITATION

The European HIV Clinical Forum 2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 4 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

 
 
SUPPORTER

The European HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

ENDORSERS
IAPAC_logo_PNG.png
Logo BHIVA-RGB.jpg
International Association of Providers of AIDS Care (IAPAC)
 
PRACTICAL INFORMATION

We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay to the European HIV Clinical Forum 2020: Optimizing Treatment.

Certificate of Attendance

A certificate of attendance will be sent by e-mail after the forum meeting in the following week.

 

Disclaimer

This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.

Language

The official language of this meeting is English.

Liability and Insurance

By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Meeting Materials

An official program and speaker's bios will be sent by e-mail one day prior to the virtual forum meeting.

 

Payment and Procedure of Online Registration

Registration is free of charge for all healthcare practitioners. You will get a confirmation of the registration within 1-5 business days. If you did not receive a confirmation, please contact the Organizing Secretariat by e-mail: Dagmar@vironet.com.

 

Contact

Inquiries

For any inquiries or questions, please contact Virology Education at info@virology-education.com or call +31 (0)30 230 7146. You can also contact us by filling out the contact form.

Inna Laven

Project Leader

Inna@vironet.com

Dagmar Jónasdóttir

Project Coordinator

Dagmar@vironet.com

Contact form